These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20712239)

  • 1. [Genetic base of heart diseases].
    Cieślewicz AR; Jabłecka A
    Pol Merkur Lekarski; 2010 Jul; 29(169):5-7. PubMed ID: 20712239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders.
    Aoki Y; Niihori T; Narumi Y; Kure S; Matsubara Y
    Hum Mutat; 2008 Aug; 29(8):992-1006. PubMed ID: 18470943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome.
    Lee ST; Ki CS; Lee HJ
    Clin Genet; 2007 Aug; 72(2):150-5. PubMed ID: 17661820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular genetic diagnostics in syndromes associated with the RAS/MAPK signalling pathway].
    Molven A; Søvik O; von der Lippe C; Steine SJ; Njølstad PR; Houge G; Prescott TE
    Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2358-61. PubMed ID: 19935936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gene therapy in heart diseases].
    Tanner FC; Largiadèr T; Yang Z; Lüscher TF
    Schweiz Med Wochenschr; 1999 Nov; 129(46):1784-91. PubMed ID: 10603653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations.
    Zenker M; Lehmann K; Schulz AL; Barth H; Hansmann D; Koenig R; Korinthenberg R; Kreiss-Nachtsheim M; Meinecke P; Morlot S; Mundlos S; Quante AS; Raskin S; Schnabel D; Wehner LE; Kratz CP; Horn D; Kutsche K
    J Med Genet; 2007 Feb; 44(2):131-5. PubMed ID: 17056636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic approach to the pathophysiology of cardiovascular disease.
    Kurabayashi M; Yazaki Y
    Int Angiol; 1996 Sep; 15(3):187-94. PubMed ID: 8971574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/MAPK pathway.
    Jorge AA; Malaquias AC; Arnhold IJ; Mendonca BB
    Horm Res; 2009; 71(4):185-93. PubMed ID: 19258709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation.
    Kobayashi T; Aoki Y; Niihori T; Cavé H; Verloes A; Okamoto N; Kawame H; Fujiwara I; Takada F; Ohata T; Sakazume S; Ando T; Nakagawa N; Lapunzina P; Meneses AG; Gillessen-Kaesbach G; Wieczorek D; Kurosawa K; Mizuno S; Ohashi H; David A; Philip N; Guliyeva A; Narumi Y; Kure S; Tsuchiya S; Matsubara Y
    Hum Mutat; 2010 Mar; 31(3):284-94. PubMed ID: 20052757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling human hematopoietic and cardiovascular diseases in zebrafish.
    North TE; Zon LI
    Dev Dyn; 2003 Nov; 228(3):568-83. PubMed ID: 14579393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTPN11 mutations are not responsible for the Cardiofaciocutaneous (CFC) syndrome.
    Kavamura MI; Pomponi MG; Zollino M; Lecce R; Murdolo M; Brunoni D; Alchorne MM; Opitz JM; Neri G
    Eur J Hum Genet; 2003 Jan; 11(1):64-8. PubMed ID: 12529707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of gene dosage imbalances in patients with Noonan syndrome using multiplex ligation-dependent probe amplification analysis.
    Nyström AM; Ekvall S; Thuresson AC; Denayer E; Legius E; Kamali-Moghaddam M; Westermark B; Annerén G; Bondeson ML
    Eur J Med Genet; 2010; 53(3):117-21. PubMed ID: 20302979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics and cardiovascular disease.
    Allen JK
    Nurs Clin North Am; 2000 Sep; 35(3):653-62. PubMed ID: 10957680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monogenic heart disease].
    Schönberger J; Ertl G
    Med Klin (Munich); 2008 Mar; 103(3):166-74. PubMed ID: 18344067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetics of congenital heart disease: a review of recent developments.
    Weismann CG; Gelb BD
    Curr Opin Cardiol; 2007 May; 22(3):200-6. PubMed ID: 17413276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulated Ras signaling in developmental disorders: new tricks for an old dog.
    Schubbert S; Bollag G; Shannon K
    Curr Opin Genet Dev; 2007 Feb; 17(1):15-22. PubMed ID: 17208427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening the human bradykinin B2 receptor gene in patients with cardiovascular diseases: identification of a functional mutation in the promoter and a new coding variant (T21M).
    Erdmann J; Hegemann N; Weidemann A; Kallisch H; Hummel M; Hetzer R; Fleck E; Regitz-Zagrosek V
    Am J Med Genet; 1998 Dec; 80(5):521-5. PubMed ID: 9880221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genes and cardiovascular diseases].
    Kwiecień J; Skrobowski A; Cholewa M
    Pol Merkur Lekarski; 2004 Jun; 16(96):507-12. PubMed ID: 15510884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.